117 related articles for article (PubMed ID: 11029781)
1. Multidisciplinary approach to selective sentinel lymph node mapping in breast cancer.
Leong SP; Morita ET; Treseler PA; Wong JH
Breast Cancer; 2000; 7(2):105-13. PubMed ID: 11029781
[TBL] [Abstract][Full Text] [Related]
2. Dye- and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: using patent blue dye and technetium-99m-labeled human serum albumin.
Tsugawa K; Noguchi M; Miwa K; Bando E; Yokoyama K; Nakajima K; Michigishi T; Tonami N; Minato H; Nonomura A
Breast Cancer; 2000 Jan; 7(1):87-94. PubMed ID: 11029778
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of the lymphoscintigraphy in the evaluation of non-axillary sentinel lymph node localization in breast cancer.
Gherghe M; Bordea C; Blidaru A
Chirurgia (Bucur); 2015; 110(1):26-32. PubMed ID: 25800312
[TBL] [Abstract][Full Text] [Related]
4. Impact of axillary nodal metastases on lymphatic mapping and sentinel lymph node identification rate in patients with early stage breast cancer.
Pelosi E; Ala A; Bellò M; Douroukas A; Migliaretti G; Berardengo E; Varetto T; Bussone R; Bisi G
Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):937-42. PubMed ID: 15838690
[TBL] [Abstract][Full Text] [Related]
5. Intradermal radioisotope is superior to peritumoral blue dye or radioisotope in identifying breast cancer sentinel nodes.
Lin KM; Patel TH; Ray A; Ota M; Jacobs L; Kuvshinoff B; Chung M; Watson M; Ota DM
J Am Coll Surg; 2004 Oct; 199(4):561-6. PubMed ID: 15454139
[TBL] [Abstract][Full Text] [Related]
6. Sentinel lymph node biopsy as an alternative to routine axillary lymph node dissection in breast cancer patients.
Noguchi M
J Surg Oncol; 2001 Feb; 76(2):144-56. PubMed ID: 11223844
[TBL] [Abstract][Full Text] [Related]
7. Final results of the Department of Defense multicenter breast lymphatic mapping trial.
Shivers S; Cox C; Leight G; Beauchamp D; Blumencranz P; Ross M; Reintgen D
Ann Surg Oncol; 2002 Apr; 9(3):248-55. PubMed ID: 11923131
[TBL] [Abstract][Full Text] [Related]
8. Lymphatic mapping and sentinel node biopsy in endometrial cancer--a feasibility study using cervical injection of radiotracer and blue dye.
Kadkhodayan S; Shiravani Z; Hasanzadeh M; Sharifi N; Yousefi Z; Fattahi A; Sadeghi R
Nucl Med Rev Cent East Eur; 2014; 17(2):55-8. PubMed ID: 25088102
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection.
Kamath VJ; Giuliano R; Dauway EL; Cantor A; Berman C; Ku NN; Cox CE; Reintgen DS
Arch Surg; 2001 Jun; 136(6):688-92. PubMed ID: 11387010
[TBL] [Abstract][Full Text] [Related]
10. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
[TBL] [Abstract][Full Text] [Related]
11. Subareolar subcutaneous injection of blue dye versus peritumoral injection of technetium-labeled human albumin to identify sentinel lymph nodes in breast cancer patients.
Reitsamer R; Peintinger F; Rettenbacher L; Prokop E; Sedlmayer F
World J Surg; 2003 Dec; 27(12):1291-4. PubMed ID: 14574485
[TBL] [Abstract][Full Text] [Related]
12. [Preliminary study on a new sentinel lymphoscintigraphy agent 99mTc-Rituximab for breast patient].
Wang XJ; Lin BH; Yang Z; Ouyang T; Li JF; Xu B; Zhang Y; Zhang MY
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):200-3. PubMed ID: 16875605
[TBL] [Abstract][Full Text] [Related]
13. Sentinel lymph node mapping in breast cancer: a critical reappraisal of the internal mammary chain issue.
Manca G; Volterrani D; Mazzarri S; Duce V; Svirydenka A; Giuliano A; Mariani G
Q J Nucl Med Mol Imaging; 2014 Jun; 58(2):114-26. PubMed ID: 24835288
[TBL] [Abstract][Full Text] [Related]
14. Sentinel lymph node biopsy in patients with primary cutaneous melanoma: study of 455 cases.
Landi G; Polverelli M; Moscatelli G; Morelli R; Landi C; Fiscelli O; Erbazzi A
J Eur Acad Dermatol Venereol; 2000 Jan; 14(1):35-45. PubMed ID: 10877250
[TBL] [Abstract][Full Text] [Related]
15. Preoperative lymphoscintigraphy for breast cancer does not improve the ability to identify axillary sentinel lymph nodes.
McMasters KM; Wong SL; Tuttle TM; Carlson DJ; Brown CM; Dirk Noyes R; Glaser RL; Vennekotter DJ; Turk PS; Tate PS; Sardi A; Edwards MJ
Ann Surg; 2000 May; 231(5):724-31. PubMed ID: 10767794
[TBL] [Abstract][Full Text] [Related]
16. Lymphoscintigraphic visualization of internal mammary nodes with subtumoral injection of radiocolloid in patients with breast cancer.
Shimazu K; Tamaki Y; Taguchi T; Motomura K; Inaji H; Koyama H; Kasugai T; Wada A; Noguchi S
Ann Surg; 2003 Mar; 237(3):390-8. PubMed ID: 12616124
[TBL] [Abstract][Full Text] [Related]
17. Breast lymphoscintigraphy for sentinel node identification in breast cancers with clinically-negative axillary nodes.
Namwongprom S; Boonyaprapa S; Ekmahachai M; Vilasdechanon N; Somwangprasert A; Sumitsawan S; Taya P
Singapore Med J; 2005 Dec; 46(12):688-92. PubMed ID: 16308641
[TBL] [Abstract][Full Text] [Related]
18. Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and technetium 99m sulfur colloid.
Kern KA
J Am Coll Surg; 2002 Oct; 195(4):467-75. PubMed ID: 12375751
[TBL] [Abstract][Full Text] [Related]
19. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer.
Cox CE; Pendas S; Cox JM; Joseph E; Shons AR; Yeatman T; Ku NN; Lyman GH; Berman C; Haddad F; Reintgen DS
Ann Surg; 1998 May; 227(5):645-51; discussion 651-3. PubMed ID: 9605656
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of lymph node status in male breast cancer patients: a role for sentinel lymph node biopsy.
Albo D; Ames FC; Hunt KK; Ross MI; Singletary SE; Kuerer HM
Breast Cancer Res Treat; 2003 Jan; 77(1):9-14. PubMed ID: 12602900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]